Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SURMODICS INC Director's Dealing 2021

Aug 13, 2021

32845_dirs_2021-08-13_335da64e-f54e-4784-ae55-f9385300f274.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2021-08-11

Reporting Person: Manders John D. (Corporate Controller)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-08-11 Common Stock M 2608 $22.95 Acquired 5716 Direct
2021-08-11 Common Stock S 2555 $53.3312 Disposed 3161 Direct
2021-08-11 Common Stock S 53 $54.24 Disposed 3108 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-08-11 Employee Stock Option (right to buy) $22.95 M 2608 Disposed 2024-05-03 Common Stock (2608) Direct

Footnotes

F1: Reflects the weighted average price of 2,555 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on August 11, 2021 with sale prices ranging from $53.1458 to $53.72 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2: Fully vested.